Centiva Capital’s IRIDEX IRIX Stock Holding History

Centiva Capital’s Portfolio IRIX Stock Details IRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13,920	Closed	-$15.9K	–	1933
2026 Q2	$15.9K	Buy	+13,920	New	+$14.9K	﹤0.01%	1724
2025 Q4	–	Sell	-18,768	Closed	-$21.6K	–	1440
2025 Q3	$21.6K	Buy	+18,768	New	+$23.1K	﹤0.01%	985

Other funds holding IRIX

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

United Capital Financial Advisors Irving, Texas $18.4B AUM 17.63% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Centiva Capital's IRIX Position: Q3 2026 in Review

Centiva Capital sold out of IRIDEX (IRIX) in Q3 2026, closing a stake of 13,920 shares — an estimated $15.9K sold.

Centiva Capital first reported a position in IRIX in Q3 2025 and held it in 2 quarters. The position peaked at $21.6K in Q3 2025. 21 funds tracked by Wall St. Rank hold IRIX as of Q3 2026.

Centiva Capital reported no remaining IRIDEX position as of Q3 2026 after selling out during the quarter.
Centiva Capital sold 13,920 IRIDEX shares in Q3 2026, an estimated $15.9K.
Centiva Capital first reported a position in IRIDEX in Q3 2025 and held it in 2 quarters.
Centiva Capital's IRIDEX position peaked at $21.6K in Q3 2025.
21 funds tracked by Wall St. Rank held IRIDEX as of Q3 2026.

Based on Centiva Capital's 13F filing for Q3 2026, filed 13 Nov 2026.